The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of ...
The Burning Crusade Classic Phase 2, styled the Overlords of Outland, launches worldwide on WoW Classic Anniversary realms on ...
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.
Soldiers Don't Wait for AI. They Build It.300+ Participants. 42 Teams. Five Days to Build the Army's AI Future.By MAJ Zak ...
For decades, the treatment of developmental and epileptic encephalopathies has focused on suppressing seizures rather than modifying the underlying biology of disease. In the New England Journal of ...
A startup called First American Nuclear, or FANCO, wants to build something the United States has never had: a commercial ...